{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:21:38Z","timestamp":1783948898414,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:00:00Z","timestamp":1347408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00417-012-2153-y","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T02:11:05Z","timestamp":1347329465000},"page":"261-270","source":"Crossref","is-referenced-by-count":68,"title":["Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections"],"prefix":"10.1007","volume":"251","author":[{"given":"Sung Jun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler Hyung Taek","family":"Rim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Yeob","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jig","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yeul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sook","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"2153_CR1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 ophthalmopathy. N Engl J Med 362:726\u2013738","journal-title":"N Engl J Med"},{"key":"2153_CR2","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2002-030010","volume":"88","author":"RS Bahn","year":"2003","unstructured":"Bahn RS (2003) Clinical review 157: pathophysiology of Graves\u2019 ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 88:1939\u20131946","journal-title":"J Clin Endocrinol Metab"},{"key":"2153_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000417913","volume":"20","author":"CA Gorman","year":"1989","unstructured":"Gorman CA, Bahn RS (1989) Pathogenesis of Graves\u2019 ophthalmopathy. Dev Ophthalmol 20:1\u20137","journal-title":"Dev Ophthalmol"},{"key":"2153_CR4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","volume":"121","author":"GB Bartley","year":"1996","unstructured":"Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA (1996) Clinical features of Graves\u2019 ophthalmopathy in an incidence cohort. Am J Ophthalmol 121:284\u2013290","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2153_CR5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/eye.2011.359","volume":"26","author":"YJ Choi","year":"2012","unstructured":"Choi YJ, Lim HT, Lee SJ, Lee SY, Yoon JS (2012) Assessing Graves\u2019 ophthalmopathy\u2014specific quality of life in Korean patients. Eye (Lond) 26(4):544\u2013551","journal-title":"Eye (Lond)"},{"key":"2153_CR6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1530\/EJE-11-0055","volume":"164","author":"S Estcourt","year":"2011","unstructured":"Estcourt S, Quinn AG, Vaidya B (2011) Quality of life in thyroid eye disease: impact of quality of care. Eur J Endocrinol 164:649\u2013655","journal-title":"Eur J Endocrinol"},{"key":"2153_CR7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/thy.1997.7.885","volume":"7","author":"MN Gerding","year":"1997","unstructured":"Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM (1997) Quality of life in patients with Graves\u2019 ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 7:885\u2013889","journal-title":"Thyroid"},{"key":"2153_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3341\/kjo.2010.24.2.65","volume":"24","author":"H Lee","year":"2010","unstructured":"Lee H, Roh HS, Yoon JS, Lee SY (2010) Assessment of quality of life and depression in Korean patients with Graves\u2019 ophthalmopathy. Korean J Ophthalmol 24:65\u201372","journal-title":"Korean J Ophthalmol"},{"key":"2153_CR9","first-page":"94","volume":"140","author":"GJ Ben Simon","year":"2005","unstructured":"Ben Simon GJ, Mansury AM, Schwarcz RM, Modjtahedi S, McCann JD, Goldberg RA (2005) Transconjunctival Muller muscle recession with levator disinsertion for correction of eyelid retraction associated with thyroid-related orbitopathy. Am J Ophthalmol 140:94\u201399","journal-title":"Am J Ophthalmol"},{"key":"2153_CR10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/eye.2008.165","volume":"23","author":"PG Costa","year":"2009","unstructured":"Costa PG, Saraiva FP, Pereira IC, Monteiro ML, Matayoshi S (2009) Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage. Eye (Lond) 23:767\u2013773","journal-title":"Eye (Lond)"},{"key":"2153_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/IOP.0b013e31802c602c","volume":"23","author":"H Demirci","year":"2007","unstructured":"Demirci H, Hassan AS, Reck SD, Frueh BR, Elner VM (2007) Graded full-thickness anterior blepharotomy for correction of upper eyelid retraction not associated with thyroid eye disease. Ophthal Plast Reconstr Surg 23:39\u201345","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"2153_CR12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0161-6420(82)34861-7","volume":"89","author":"R Dixon","year":"1982","unstructured":"Dixon R (1982) The surgical management of thyroid-related upper eyelid retraction. Ophthalmology 89:52\u201357","journal-title":"Ophthalmology"},{"key":"2153_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ajo.2005.08.044","volume":"141","author":"VM Elner","year":"2006","unstructured":"Elner VM, Hassan AS, Frueh BR (2006) Transconjunctival Muller muscle recession with levator disinsertion for correction of eyelid retraction associated with thyroid-related orbitopathy. Am J Ophthalmol 141:233, author reply 233\u2013234","journal-title":"Am J Ophthalmol"},{"key":"2153_CR14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/ICU.0b013e3283499433","volume":"22","author":"M Kazim","year":"2011","unstructured":"Kazim M, Gold KG (2011) A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease. Curr Opin Ophthalmol 22:391\u2013393","journal-title":"Curr Opin Ophthalmol"},{"key":"2153_CR15","first-page":"318","volume":"22","author":"JJ Older","year":"1991","unstructured":"Older JJ (1991) Surgical treatment of eyelid retraction associated with thyroid eye disease. Ophthalmic Surg 22:318\u2013322, discussion 322\u2013313","journal-title":"Ophthalmic Surg"},{"key":"2153_CR16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0161-6420(81)34987-2","volume":"88","author":"AM Putterman","year":"1981","unstructured":"Putterman AM (1981) Surgical treatment of thyroid-related upper eyelid retraction. Graded Muller\u2019s muscle excision and levator recession. Ophthalmology 88:507\u2013512","journal-title":"Ophthalmology"},{"key":"2153_CR17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/01676830903324268","volume":"29","author":"H Salour","year":"2010","unstructured":"Salour H, Bagheri B, Aletaha M, Babsharif B, Kleshadi M, Abrishami M, Bagheri A (2010) Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease. Orbit 29:114\u2013118","journal-title":"Orbit"},{"key":"2153_CR18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1034\/j.1600-0420.2001.790608.x","volume":"79","author":"F Traisk","year":"2001","unstructured":"Traisk F, Tallstedt L (2001) Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction\u2014a pilot study. Acta Ophthalmol Scand 79:585\u2013588","journal-title":"Acta Ophthalmol Scand"},{"key":"2153_CR19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0161-6420(02)01041-2","volume":"109","author":"JM Uddin","year":"2002","unstructured":"Uddin JM, Davies PD (2002) Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology 109:1183\u20131187","journal-title":"Ophthalmology"},{"key":"2153_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IOP.0b013e3181c2a16d","volume":"27","author":"R Mancini","year":"2011","unstructured":"Mancini R, Khadavi NM, Goldberg RA (2011) Nonsurgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler. Ophthal Plast Reconstr Surg 27:1\u20133","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"2153_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000310837","volume":"211","author":"SB Ozkan","year":"1997","unstructured":"Ozkan SB, Can D, Soylev MF, Arsan AK, Duman S (1997) Chemodenervation in treatment of upper eyelid retraction. Ophthalmologica 211:387\u2013390","journal-title":"Ophthalmologica"},{"key":"2153_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.iop.0000235820.00633.61","volume":"22","author":"RA Goldberg","year":"2006","unstructured":"Goldberg RA, Fiaschetti D (2006) Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg 22:335\u2013341, discussion 341\u2013333","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"2153_CR23","first-page":"10004","volume":"1","author":"SC Werner","year":"1966","unstructured":"Werner SC (1966) Prednisone in emergency treatment of malignant exophthalmos. Lancet 1:10004\u201310007","journal-title":"Lancet"},{"key":"2153_CR24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archopht.1968.03850040281009","volume":"79","author":"RM Day","year":"1968","unstructured":"Day RM, Carroll FD (1968) Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction. Arch Ophthalmol 79:279\u2013282","journal-title":"Arch Ophthalmol"},{"key":"2153_CR25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0140-6736(61)90636-5","volume":"2","author":"S Gebertt","year":"1961","unstructured":"Gebertt S (1961) Depot-methylprednisolone for subconjunctival and retrobulbar injections. Lancet 2:344\u2013345","journal-title":"Lancet"},{"key":"2153_CR26","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjo.2004.046193","volume":"88","author":"R Ebner","year":"2004","unstructured":"Ebner R, Devoto MH, Weil D, Bordaberry M, Mir C, Martinez H, Bonelli L, Niepomniszcze H (2004) Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol 88:1380\u20131386","journal-title":"Br J Ophthalmol"},{"key":"2153_CR27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1755-3768.2008.01171.x","volume":"87","author":"M Bordaberry","year":"2009","unstructured":"Bordaberry M, Marques DL, Pereira-Lima JC, Marcon IM, Schmid H (2009) Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves\u2019 ophthalmopathy. Acta Ophthalmol 87:58\u201364","journal-title":"Acta Ophthalmol"},{"key":"2153_CR28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1442-9071.2010.02332.x","volume":"38","author":"AA Alkawas","year":"2010","unstructured":"Alkawas AA, Hussein AM, Shahien EA (2010) Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy. Clin Exp Ophthalmol 38:692\u2013697","journal-title":"Clin Exp Ophthalmol"},{"key":"2153_CR29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.eye.6702933","volume":"22","author":"E Chee","year":"2008","unstructured":"Chee E, Chee SP (2008) Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series. Eye (Lond) 22:311\u2013315","journal-title":"Eye (Lond)"},{"key":"2153_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol 47:9\u201314","journal-title":"Clin Endocrinol"},{"key":"2153_CR31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0733-8635(18)30318-8","volume":"10","author":"L Renfro","year":"1992","unstructured":"Renfro L, Snow JS (1992) Ocular effects of topical and systemic steroids. Dermatol Clin 10:505\u2013512","journal-title":"Dermatol Clin"},{"key":"2153_CR32","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1210\/en.141.8.2945","volume":"141","author":"JR Singleton","year":"2000","unstructured":"Singleton JR, Baker BL, Thorburn A (2000) Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis. Endocrinology 141:2945\u20132950","journal-title":"Endocrinology"},{"key":"2153_CR33","first-page":"71","volume":"39","author":"K Yoshikawa","year":"1995","unstructured":"Yoshikawa K, Kotake S, Ichiishi A, Sasamoto Y, Kosaka S, Matsuda H (1995) Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol 39:71\u201376","journal-title":"Jpn J Ophthalmol"},{"issue":"Pt 4","key":"2153_CR34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/eye.1998.168","volume":"12","author":"V Tanner","year":"1998","unstructured":"Tanner V, Kanski JJ, Frith PA (1998) Posterior sub-Tenon\u2019s triamcinolone injections in the treatment of uveitis. Eye (Lond) 12(Pt 4):679\u2013685","journal-title":"Eye (Lond)"},{"key":"2153_CR35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s004170050235","volume":"237","author":"M Lafranco Dafflon","year":"1999","unstructured":"Lafranco Dafflon M, Tran VT, Guex-Crosier Y, Herbort CP (1999) Posterior sub-Tenon\u2019s steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol 237:289\u2013295","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2153_CR36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.eye.6702667","volume":"22","author":"A Song","year":"2008","unstructured":"Song A, Carter KD, Nerad JA, Boldt C, Folk J (2008) Steroid-induced ptosis: case studies and histopathologic analysis. Eye (Lond) 22:491\u2013495","journal-title":"Eye (Lond)"},{"key":"2153_CR37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archophthalmol.2011.29","volume":"129","author":"GB Bartley","year":"2011","unstructured":"Bartley GB (2011) Rundle and his curve. Arch Ophthalmol 129:356\u2013358","journal-title":"Arch Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-2153-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-012-2153-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-2153-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T14:12:53Z","timestamp":1562163173000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-012-2153-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2153"],"URL":"https:\/\/doi.org\/10.1007\/s00417-012-2153-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}